Literature DB >> 27771234

Comparison of Conscious Sedation and Asleep-Awake-Asleep Techniques for Awake Craniotomy.

Ozlem Korkmaz Dilmen1, Eren Fatma Akcil2, Abdulvahap Oguz3, Hayriye Vehid4, Yusuf Tunali5.   

Abstract

Since awake craniotomy (AC) has become a standard of care for supratentorial tumour resection, especially in the motor and language cortex, determining the most appropriate anaesthetic protocol is very important. The aim of this retrospective study is to compare the effectiveness of conscious sedation (CS) to "awake-asleep-awake" (AAA) techniques for supratentorial tumour resection. Forty-two patients undergoing CS and 22 patients undergoing AAA were included in the study. The primary endpoint was to compare the CS and AAA techniques with respect to intraoperative pain and agitation in patients undergoing supratentorial tumour resection. The secondary endpoint was comparison of the other intraoperative complications. This study results show that the incidence of intraoperative agitation and seizure were lower in the AAA group than in the CS group. Intraoperative blood pressures were significantly higher in the CS group than in the AAA group during the pinning and incision, but the level of blood pressures did not need antihypertensive treatment. Otherwise, blood pressures were significantly higher in the AAA group than in the CS group during the neurological examination and the severity of hypertension needed statistically significant more antihypertensive treatment in the AAA group. As a result of hypertension, the amount of intraoperative bleeding was higher in the AAA group than in the CS group. In conclusion, the AAA technique may provide better results with respect to agitation and seizure, but intraoperative hypertension needed a vigilant follow-up especially in the wake-up period.
Copyright © 2016 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Awake craniotomy; Conscious sedation; Supratentorial tumour

Mesh:

Year:  2016        PMID: 27771234     DOI: 10.1016/j.jocn.2016.10.007

Source DB:  PubMed          Journal:  J Clin Neurosci        ISSN: 0967-5868            Impact factor:   1.961


  6 in total

Review 1.  Clinical applications of neurolinguistics in neurosurgery.

Authors:  Peng Wang; Zehao Zhao; Linghao Bu; Nijiati Kudulaiti; Qiao Shan; Yuyao Zhou; N U Farrukh Hameed; Yangming Zhu; Lei Jin; Jie Zhang; Junfeng Lu; Jinsong Wu
Journal:  Front Med       Date:  2021-05-12       Impact factor: 4.592

Review 2.  Anesthetic considerations for awake craniotomy.

Authors:  Seung Hyun Kim; Seung Ho Choi
Journal:  Anesth Pain Med (Seoul)       Date:  2020-07-31

3.  Performing Awake Surgeries in Times of COVID-19 - A Singapore Experience.

Authors:  Swati Jain; Will Loh; Hui-Minn Chan; Calvin Lam; Tseng Tsai Yeo; Lwin Sein; Vincent Nga; Kejia Teo
Journal:  Asian J Neurosurg       Date:  2021-12-18

4.  Serum Concentration of Ropivacaine After Repeated Administration to Several Parts of the Head During Awake Craniotomy: A Prospective Cohort Study.

Authors:  Takehito Sato; Takahiro Ando; Ichiko Asano; Atsushi Mori; Kazuya Motomura; Kimitoshi Nishiwaki
Journal:  Front Med (Lausanne)       Date:  2022-05-04

Review 5.  Glioblastoma Treatment: State-of-the-Art and Future Perspectives.

Authors:  Alejandro Rodríguez-Camacho; José Guillermo Flores-Vázquez; Júlia Moscardini-Martelli; Jorge Alejandro Torres-Ríos; Alejandro Olmos-Guzmán; Cindy Sharon Ortiz-Arce; Dharely Raquel Cid-Sánchez; Samuel Rosales Pérez; Monsserrat Del Sagrario Macías-González; Laura Crystell Hernández-Sánchez; Juan Carlos Heredia-Gutiérrez; Gabriel Alejandro Contreras-Palafox; José de Jesús Emilio Suárez-Campos; Miguel Ángel Celis-López; Guillermo Axayacalt Gutiérrez-Aceves; Sergio Moreno-Jiménez
Journal:  Int J Mol Sci       Date:  2022-06-29       Impact factor: 6.208

6.  Intra- and postoperative adverse events in awake craniotomy for intrinsic supratentorial brain tumors.

Authors:  Borys M Kwinta; Aneta M Myszka; Monika M Bigaj; Roger M Krzyżewski; Anna Starowicz-Filip
Journal:  Neurol Sci       Date:  2020-08-17       Impact factor: 3.307

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.